A simple, automated, and individualized insulin-pump calibration system based on a series of measures taken before and a few hours after carbohydrate ingestion, which modulate the shape of pre-meal insulin dosing to explicitly reduce postprandial BG levels while minimizing the likelihood of dangerously low BG.
Abstract
The successful management of type-1 diabetes (T1D) and insulin-dependent type-2 diabetes depends on the ability to accurately calibrate bolus and basal insulin doses, and minimize the time spent with high postprandial blood glucose (BG) levels while avoiding dangerously low hypoglycemic excursions. Precise calibration of the insulin pump helps with successful disease management; however, people with T1D may still experience prolonged, potentially damaging BG levels due to postprandial highs. Insulin pumps offer large, currently underexploited degrees of freedom in insulin delivery, which can have a dramatic impact on average postprandial BG levels. Building on existing models of the glucose-insulin system, we first propose a simple, automated, and individualized insulin-pump calibration system based on a series of measures taken before and a few hours after carbohydrate ingestion. We then modulate the shape of pre-meal insulin dosing to explicitly reduce postprandial BG levels while minimizing the likelihood of dangerously low BG. Such an optimal insulin delivery time course can potentially improve postprandial BG levels and rapidly bring BG to the target level. We evaluated our methods in 20 patients over 4 days, with BG levels sampled frequently.
Randomized and real-world studies demonstrate that AID systems significantly improve A1C and time in range while minimizing hypoglycemia, without increasing treatment complexity or patient burden, and position AID as a practical and effective strategy to overcome long-standing therapeutic inertia in type 2 diabetes.
Z. Tariq, Grazia Aleppo, Anders L. Carlson et al.· Endocrine Practice· 0 citations
Type-I Diabetes Mellitus (TIDM) is characterized by
autoimmune destruction of pancreatic β-cells, resulting in absolute insulin deficiency and
impaired glucose regulation. Maintaining normoglycemia is challenging due to the nonlinear and
time-varying nature of Glucose–Insulin (GI) dynamics, meal disturbances, and p...
A. Patra, Smitta Ranjan Dutta, Anuja Nanda· Current Science, Engineering...· 0 citations
An artificial pancreas (AP) is a biomedical device that mimics the natural glucose-regulation process carried out by a healthy pancreas. This device consists of three parts: a continuous glucose monitor (CGM), a control algorithm, and an insulin pump. These three parts work together by continuously monitoring blood glu...
L. T. Rasheed, A. Alaraji, T. Mohammadridha· Iraqi Journal of Computers,...· 0 citations
CGM-informed basal insulin optimization with a prototype of Dexcom Smart Basal was associated with improvements in glycemic control and treatment satisfaction in adults with T2D, with a favorable safety profile, and the system may help overcome clinical inertia and support individualized insulin titration in real-world...
S. Oser, C. Crystal, K. Hames et al.· Diabetes Therapy· 0 citations
Sliding-scale insulin is the default hospital response to high blood glucose. Its correction factor was designed for patients who make no insulin, yet it is routinely ordered for patients whose pancreas still works, including those on high-dose steroids. We treat the sliding scale as what it is, a proportional controll...
INTRODUCTION
Basal insulin dose titration has historically relied on fasting self-monitoring blood glucose (SMBG) and hypoglycemic events. This retrospective analysis of the QWINT-2 and QWINT-3 Phase 3 trials aimed to evaluate the use of continuous glucose monitoring (CGM)-derived indicators for weekly insulin efsitora...
R. Bergenstal, Michael B. Davidson, David T. Ahn et al.· Diabetes Technology & Therap...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.